L-Leucinamide,N-[(phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-;MG-132;(S)-MG132;Benzyl (S)-4-methyl-1-((S)-4-methyl-1-((S)-4-methyl-1-oxopentan-2-ylamino)-1-oxopentan-2-ylamino)-1-oxopentan-2-ylcarbamate;benzyl N-[(2S)-4-methyl-1-[[(2S)-4-methyl-1-[[(2S)-4-methyl-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]amino]-1-oxopentan-2-yl]carbamate;CALPAIN INHIBITOR IV;MG 132 (MG-132);MG-132-1;N-CBZ-LEU-LEU-LEU-AL;ProteasoMe Inhibitor MG-132;Z-Leu-Leu-Leu-H (Aldehyde);MG132;Carbobenzoxy-L-leucyl-L-leucyl-L-leucinal;Cbz-Leu-Leu-Leu-H;Z-LEU-LEU-LEU-AL;Z-Leu-Leu-Leu-CHO;Z-Leu-Leu-Leu-H;Z-LLL-CHO;Calpain inhibitor IV-2;N-[(Phenylmethoxy)carbonyl]-L-leucyl-N-[(1S)-1-formyl-3-methylbutyl]-L-leucinamide;Z-LL-CHO;MG132/MG-132;MG-132, >=98%;Z-LEU-LEU-LEU-H;z-leu-leu-leu-al;Z-LEU-LEU-LEU-CHO;Z-LEU-LEU-ALDEHYDE